• Latest
    • Big pharma
    • Biotechnology
    • CRISPR
    • Generics
    • Unified Patent Court
  • Regions
    • Americas
    • Europe
    • Asia
    • Asia-Pacific
  • Careers
  • Events
    • Conferences
    • Conference Videos
    • Webinars
  • Directory
  • Magazines
  • About
  • Contact
  • Newsletter
  • Login
  • Subscribe
  • Home
  • About
  • Contact
  • Newsletter
  • Login


Subscribe
  • Home
  • Plastic surgery clinic targets former employees in copyright and TM suit
trademark-istock-508118711-timarbaev-
timarbaev / iStockphoto.com
11 January 2019Medtech

Plastic surgery clinic targets former employees in copyright and TM suit

A New York-based plastic surgery clinic has taken legal action against two former employees and a rival clinic for copyright infringement, trademark counterfeiting and dilution, and cybersquatting.

Already registered?

Login to your account


If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.

For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Cosmetic surgery firm sued over ‘smaller breasts’ blog image
17 December 2018   A Florida-based photo agency has accused San Francisco Plastic Surgery & Laser Center of using a copyright-protected image without authorisation on a web page about breast implants.


Editor's picks

New AIPLA president calls for greater certainty in US patent law
Americas
New AIPLA president calls for greater certainty in US patent law
6 November 2025

Editor's picks

Americas
New AIPLA president calls for greater certainty in US patent law
6 November 2025

More features

Pfizer can’t block Novo Nordisk’s $10bn takeover deal
WBD adds litigation firepower in Silicon Valley with DLA Piper veteran
New AIPLA president calls for greater certainty in US patent law
Regeneron and CureVac: UPC ‘cannot be ignored’
US generics company wins patent battle over Merck Serono’s blockbuster MS drug
Novartis counsel warns: ‘Don’t let AI develop without our input’
Squires: ‘Inherited patent backlog was an absolute dumpster fire’
Is Hatch-Waxman litigation for orphan drugs working?

  • Home
  • News
  • About us
  • Contact
  • Terms of Use
  • Privacy Policy
  • Terms of Subscription

LSIPR
Newton Media Ltd
Kingfisher House
21-23 Elmfield Road
BR1 1LT
United Kingdom

  • Twitter
  • Linkedin